Showing 731-740 of 1110 results for "".
- Moran Eye Center Lab Produces World’s First ‘Pathoconnectome’https://modernod.com/news/moran-eye-center-lab-produces-worlds-first-pathoconnectome/2478338/Scientists from the John A. Moran Eye Center at the University of Utah have achieved another first in the field of connectomics, which studies the synaptic connections between neurons. Moran’s Marclab for Connectomics was the first to complete a map of the circuitry of the retina, or conne
- Researchers Look To Behavior To Explore Why The Coronavirus May Hit Men Harderhttps://modernod.com/news/researchers-look-to-behavior-to-explore-why-the-coronavirus-may-hit-men-harder/2477641/Researchers suspect that the coronavirus is hitting men and women differently. Worldwide, men appear more likely to suffer more severely or die from COVID-19 than women. But experts don’t know why. At Johns Hopkins University, researchers have begun to
- Could a Hormone be Used to Treat Eye Disease?https://modernod.com/news/could-a-hormone-be-used-to-treat-eye-disease/2477314/John A. Moran Eye Center researchers continue to shed new light on the potential of the hormone erythropoietin (EPO) to treat eye disease. EPO increases red blood cell production, and is already used clinically to treat anemia. However, more recently EPO is being recognized for other properties,
- Second Sight Announces $2.4 Million, 4-Year Grant from NIH to Develop Spatial Localization and Mapping Technologyhttps://modernod.com/news/second-sight-announces-2-4-million-4-year-grant-from-nih-to-develop-spatial-localization-and-mapping-technology/2476926/Second Sight Medical Products announced receipt of a $2.4 million, 4-year grant from the National Institutes of Health (NIH) to develop spatial localization and mapping technology (SLAM). A joint collaboration with the Johns Hopkins University Applied Physics Laboratory (APL), the initiative is i
- Oyster Point Pharma Expands Executive Leadership Teamhttps://modernod.com/news/oyster-point-pharma-expands-executive-leadership-team/2476896/Oyster Point Pharma announced the appointment of Dan Lochner, MBA, as its Chief Financial Officer, and John Snisarenko, MBA, as Chief Commercial Officer. Mr. Lochner joins Oyster Point Pharma after spending nearly 15 years, most recently as a Managing Director, at Goldman Sachs asset mana
- Investigators Seek Optimized Ophthalmology Clinical Trial Outcomeshttps://modernod.com/news/investigators-seek-optimized-ophthalmology-clinical-trial-outcomes/2476338/Investigators from Brown University and Johns Hopkins University shared new considerations from 3 groups working to standardize Core Outcome Sets (COSs), to increase the utility of results from randomized clinical trials for 3 eye conditions: age-related macular degeneration (AMD), refractive err
- Pennsylvania Senate Approves Bill That Would Expand Optometrists’ Scope of Practicehttps://modernod.com/news/pennsylvania-senate-approves-bill-that-would-expand-optometrists-scope-of-practice/2479790/A Pennsylvania bill – Senate Bill (SB) 668, introduced by Sen. John Gordner – seeks to expand optometrists’ scope of practice beyond the limits of their training. The bill passed the full Senate by a vote of 32-17 on Sept. 25, 2018, and it now awaits consideration by the House Professional Licens
- ScienceBased Health Expands Its Ophthalmology Clinical Advisory Panelhttps://modernod.com/news/sciencebased-health-expands-its-ophthalmology-clinical-advisory-panel/2482806/ScienceBased Health (SBH) today announced the addition of Nicole Fram, MD, Jennifer Loh, MD and Gary Wörtz, MD to its Ophthalmology Clinical Advisory Panel. The organi
- Ace Vision Group Adds Four Ophthalmologists to Medical Advisory Board; Launches New Corporate and Medical Affairs Websiteshttps://modernod.com/news/ace-vision-group-adds-four-ophthalmologists-to-medical-advisory-board-launches-new-corporate-and-medical-affairs-websites/2481941/Ace Vision Group announced the addition of Cathleen McCabe, MD; James Katz, MD; Ehsan Sadri, MD; and Dagny Zhu, MD, to its medical advisory board. These prominent ophthalmologists will contribute expertise to advance the development and implementation of novel solutions for e
- Visus Therapeutics Expands Clinical Advisory Board With Appointment of Renowned Ophthalmologistshttps://modernod.com/news/visus-therapeutics-expands-clinical-advisory-board-with-appointment-of-renowned-ophthalmologists/2478453/Visus Therapeutics announced the appointments of prominent ophthalmologists Marguerite McDonald, MD, Neda Shamie, MD, William Trattler, MD, and Lawrence Woodard, MD, to its clinical advisory board. Drs. McDonald, Shamie, Trattler and Woodard will lend their decades of experience in clinical pract